Cancer Moonshot℠ - Blue Ribbon Panel - Funding Opportunities - National Cancer Institute

Cancer Moonshot℠ - Blue Ribbon Panel - Funding Opportunities - National Cancer Institute

Cancer MoonshotSM

Updates from the National Cancer Institute

NCI has identified additional funding opportunity announcements (FOAs) from within NCI’s extensive funding portfolio that are aligned with the goals of the Cancer Moonshot. These, in addition to the FOAs that were identified in December, 2016, mark the beginning of a growing Cancer Moonshot portfolio. Planning for implementation of longer-term Cancer Moonshot-related scientific initiatives and associated funding opportunities is also underway. Learn more about these FOAs.

Cancer Moonshot℠ – Funding Opportunities

• 
• 
• 
• 
• 
• 
• 

The 21st Century Cures Act was signed into law in December 2016, and authorizes $1.8 billion over 7 years to fund the Beau Biden Cancer Moonshot. This additional funding enables NCI to accelerate research initiatives aligned with the Cancer Moonshot and to build upon ongoing efforts in advancing cancer research.

Following receipt of the Blue Ribbon Panel report, NCI identified funding opportunity announcements (FOAs) from within its extensive research portfolio that aligned with the goals of the Cancer Moonshot and that could be leveraged with existing funds. We posted those FOAs here to simplify the process of searching for funding opportunities to support Cancer Moonshot-related research. These opportunities mark the beginning of a growing Cancer Moonshot portfolio.

Planning for implementation of longer-term scientific initiatives is also underway. We have established implementation teams aligned with the BRP recommendations. The teams include NCI extramural and intramural scientists, and experts from several other NIH institutes and centers. Team members are considering multiple ways to fund the best science, including grants, supplements, and other mechanisms, and, where appropriate, to form partnerships with foundations, academia, and the private sector. We look forward to engaging our extramural colleagues in this process.

We will continue to update this page as new funding opportunities become available. Please check back often or sign up to receive automatic email updates for these announcements and other Cancer Moonshot-related activities.

Open Funding Opportunity Announcements (FOA)

ENLARGE

BRP Recommendation	Title	Announcement Number	Opening Date	Expiration Date
Cancer Immunotherapy Translational Science Network	Collaborative Research Projects to Enhance Applicability of Mammalian Models for Translational Research (Collaborative R01)	PAR-16-058	1/5/2016	5/8/2017
Cancer Immunotherapy Translational Science Network	Metabolic Reprogramming to Improve Immunotherapy (R01)	PAR-16-228	9/5/2016	9/8/2019
Cancer Immunotherapy Translational Science Network	Metabolic Reprogramming to Improve Immunotherapy (R21)	PAR-16-229	9/16/2016	9/8/2019
Cancer Immunotherapy Translational Science Network	Canine Immunotherapy Trials and Correlative Studies (U01)	RFA-CA-17-001	2/7/2017	3/8/2017
Cancer Immunotherapy Translational Science Network	Coordinating Center for Canine Immunotherapy Trials and Correlative Studies (U24)	RFA-CA-17-002	2/7/2017	3/8/2017
Cancer Immunotherapy Translational Science Network	Consortium for Pancreatic Ductal Adenocarcinoma (PDAC) Translational Studies on the Tumor Microenvironment (U01)	RFA-CA-17-015	2/7/2017	3/8/2017
Cancer Immunotherapy Translational Science Network	Resource Center for the Consortium for Pancreatic Ductal Adenocarcinoma (PDAC) Translational Studies (U24)	RFA-CA-17-016	2/7/2017	3/8/2017
Cancer Immunotherapy Translational Science Network	Cancer Immune Monitoring and Analysis Centers (CIMACs) (U24)	RFA-CA-17-005	2/17/2017	3/18/2017
Cancer Immunotherapy Translational Science Network	Cancer Immunologic Data Common (CIDC) (U24)	RFA-CA-17-006	2/17/2017	3/18/2017
Therapeutic Target Identification to Overcome Resistance	Mechanisms of Cancer Drug Resistance and Sensitivity (U54)	RFA-CA-17-009	2/3/2017	3/4/2017
National Cancer Data Ecosystem	PDX Development and Trial Centers (PDTCs) (U54)	RFA-CA-17-003	2/3/2017	3/4/2017
National Cancer Data Ecosystem	PDX Data Commons and Coordinating Center (PDCCC) for the PDX Development and Trial Centers Research Network (PDXNet) (U24)	RFA-CA-17-004	2/3/2017	3/4/2017
Fusion Oncoproteins in Childhood Cancers	Gene Fusions in Pediatric Sarcomas (R01)	PA-16-251	9/5/2016	5/8/2019
Fusion Oncoproteins in Childhood Cancers	Gene Fusions in Pediatric Sarcomas (R21)	PA-16-252	9/16/2016	5/8/2019
Fusion Oncoproteins in Childhood Cancers	Administrative Supplements to Promote Research Collaborations on Fusion Oncoproteins as Drivers of Childhood Cancer (Admin Supp)	PA-17-138	3/1/2017	3/29/2018
Generation of Human Tumor Atlases	Emerging Questions in Cancer Systems Biology (U01)	PAR-16-131	5/24/2016	11/24/2018
New Enabling Technologies	Activities to Promote Technology Research Collaborations (APTRC) for Cancer Research (Admin Supp)	PA-17-143	3/12/2017	12/13/2017

• Updated: February 17, 2017